Home » news health » As pharma funding for CME goes down attendance at non-accredited industry offerings goes up
As pharma funding for CME goes down attendance at non-accredited industry offerings goes up
Docs will go for supported educational offerings no matter what, but not as many will be vetted for CME thanks to the efforts of the pharmascolds. Many of these are the increasingly popular branded med-ed offerings, often piggybacked onto large accredited meetings.
The importance of accredited CME is inflated in public perception. State licensing requirements for CME can be met with little effort or learning. Doctors′ attendance at meetings and reading choices are driven by their professional educational needs, not by CME requirements.
Related Posts
- An algorithmic approach to the ECG differentiation of narrow QRS tachycardias
- Angioedema
- What were the most important issues in hospital medicine in 2010?
- More on the differential diagnosis of wide complex tachycardia
- How to cite twitter, how to cite tweets, how to archive tweets
- Comparative effectiveness video
- Clarity regarding perioperative beta blockers
- Donald Berwick: let evidence based medicine take a back seat?
- Toxic epidermal necrolysis and Stevens-Johnson syndrome
- If you're more interested in getting your paper cited by the New York Times than by UptoDate
- The cardiovascular manifestations of systemic sclerosis (SSc)
- AMA's membership decline
- Recent antibiotic exposure, microbiology and outcomes in severe sepsis
- DRESS syndrome: another review
- Another review of ITP
Incoming search terms for the article:
Related ads As pharma funding for CME goes down attendance at non-accredited industry offerings goes up
Advertisement by : 
.
Posting Article by Author blog.
